Drug Approvals

FDA Approves Eli Lilly's Zepbound for Obstructive Sleep Apnea

FDA · obesity · 4 min

BIO 2026 Preview: Companies to Watch and Key Catalysts

FDA · 4 min

FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer

FDA · 2 min

Clene's CNM-Au8 Gets FDA Green Light for Accelerated Approval Pathway in ALS Treatment

FDA · 2 min

Novartis Receives Health Canada Approval for Fabhalta Oral Treatment for C3G Patients

2 min

ASCO 2026: Cellectar's Waldenström Macroglobulinemia Data

general · 3 min

FDA Approves LANGLARA Interchangeable Biosimilar to Lantus Insulin - Lannett Company Enters Diabetes Market

FDA · Diabetes/Endocrinology · 4 min

FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis and Blood Disorders

FDA · Hematology/Oncology · 3 min

Arvinas VEPPANU (Vepdegestrant) Receives FDA Approval as First PROTAC Drug for ESR1-Mutated Breast Cancer

FDA · Oncology - Advanced Breast Cancer · 3 min

NIKTIMVO (Axatilimab) Approved in Australia as First-in-Class Chronic Graft-Versus-Host Disease Treatment

2 min

FDA Approval for Pfizer's Breast Cancer Drug: Vepdegestrant

FDA · advanced or metastatic HR-positive, HER2-negative breast cancer · 13 min

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min